Incidents of infant bleeding are on the rise, linked to parents refusing vitamin K shots due to increasing mistrust in medical practices. A study of 11 million infants conducted between 2017 and 2025 revealed a decrease in vitamin K shot administration from 97.7% to 95%. Simultaneously, vitamin K deficiency bleeding (VKDB) increased by 347%, as reported in JAMA Pediatrics by researchers from Virginia Commonwealth University.
Vitamin K’s Role in Newborns
Newborns naturally have low vitamin K levels. The vitamin is crucial for blood clotting. Little of it crosses the placenta, and breast milk contains minimal amounts. Moreover, an infant’s gut bacteria, which help produce vitamin K, are not yet developed. Since 1961, vitamin K shots have aimed to mitigate these risks, according to the Centers for Disease Control and Prevention (CDC).
“We knew from prior studies that vitamin K refusal had been increasing in the U.S., and we wanted to learn if there were any real-life consequences of this trend,” said Dr. Elizabeth Wolf, lead researcher at VCU.
The findings confirmed rising rates of VKD (vitamin K deficiency) and VKDB (vitamin K deficiency bleeding), both of which rose significantly over the study period.
Health Implications and Risks
Vitamin K deficiency in newborns can lead to bruising and bleeding at the umbilicus within the first week after birth. Beyond one week, there is a 30% to 60% risk of intracranial hemorrhage, which may cause seizures, permanent brain damage, or death. The research highlighted that 7% of vitamin K-deficient babies and 2% of those with VKDB developed bleeding in the brain.
Addressing the Trend
Dr. Wolf emphasized the need for clear public health messaging about vitamin K administration. “Similar to the recent measles outbreaks, we are seeing the real-world implications of growing mistrust of doctors and public health professionals. We need to better understand why parents are refusing vitamin K and what can be done to improve the uptake of this important medication,” she stated.

The Future of MAHA in American Health Politics
Insulin Cost Caps Gaining Support Amid Rising Prices
Efforts to Counter Food Assistance Cutbacks in San Diego
A Personal Journey Through Encephalitis
Low-Cost Medication May Benefit Stroke Survivors
The Complex Debate Over Kratom Use in the U.S.